| Alberta Jean Palmer, FNP | |
|
409 8th St, Abernathy, TX 79311-3416 | |
| (806) 298-5884 | |
| (806) 298-5889 |
| Full Name | Alberta Jean Palmer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 409 8th St, Abernathy, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649226424 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 533693 (Texas) | Primary |
| Entity Name | Covenant Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376598904 PECOS PAC ID: 6901889393 Enrollment ID: O20040608000563 |
News Archive
Researchers have said that the UK guidance on preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from being imported via air travel does prevent a significant proportion of infectious travelers from putting people at risk of coronavirus disease 2019 (COVID-19).
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
Viewing sexually explicit material through media such as the Internet, videos, and magazines may be directly linked with the sexual behavior of adolescents and young adults, but only to a very small extent. That is the conclusion of a new study published in The Journal of Sexual Medicine.
Nivolumab has been approved since April 2016 as a checkpoint inhibitor for the treatment of adults with advanced renal cell cancer who have already undergone prior therapy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alberta Jean Palmer, FNP 3420 22nd Pl, Lubbock, TX 79410-1314 Ph: (806) 725-5844 | Alberta Jean Palmer, FNP 409 8th St, Abernathy, TX 79311-3416 Ph: (806) 298-5884 |
News Archive
Researchers have said that the UK guidance on preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from being imported via air travel does prevent a significant proportion of infectious travelers from putting people at risk of coronavirus disease 2019 (COVID-19).
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
Viewing sexually explicit material through media such as the Internet, videos, and magazines may be directly linked with the sexual behavior of adolescents and young adults, but only to a very small extent. That is the conclusion of a new study published in The Journal of Sexual Medicine.
Nivolumab has been approved since April 2016 as a checkpoint inhibitor for the treatment of adults with advanced renal cell cancer who have already undergone prior therapy.
› Verified 8 days ago